Common variants at PVT1, ATG13-AMBRA1, AHI1 and CLEC16A are associated with selective IgA deficiency

Nature Genetics

Volumn 48, Issue 11, 2016, Pages 1425-1429

  Bronson, Paola G ^a   Chang, Diana ^a   Bhangale, Tushar ^a   Seldin, Michael F ^b   Ortmann, Ward ^a   Ferreira, Ricardo C ^c   Urcelay, Elena ^d   Pereira, Luis Fernández ^e   Martin, Javier ^f   Plebani, Alessandro ^g   Lougaris, Vassilios ^g   Friman, Vanda ^h   Freiberger, Tomáš ^i,j   Litzman, Jiri ^k   Thon, Vojtech ^j,k   Pan Hammarström, Qiang ^l   Hammarström, Lennart ^l   Graham, Robert R ^a   Behrens, Timothy W ^a  

^a GENENTECH INC   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^d HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^e HOSPITAL SAN PEDRO DE ALCÁNTARA   (Spain)

^f INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^g UNIVERSITY OF BRESCIA   (Italy)

^h UNIVERSITY OF GOTHENBURG   (Sweden)

ⁱ CENTRE FOR CARDIOVASCULAR SURGERY AND TRANSPLANTATION   (Czech Republic)

^j MASARYK UNIVERSITY   (Czech Republic)

^k ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

^l KAROLINSKA INSTITUTE   (Sweden)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HLA DQA1 ANTIGEN; IMMUNOGLOBULIN A; AHI1 PROTEIN, HUMAN; AMBRA1 PROTEIN, HUMAN; ATG13 PROTEIN, HUMAN; AUTOPHAGY RELATED PROTEIN; CLEC16A PROTEIN, HUMAN; GLUCOSE TRANSPORTER; LECTIN; LONG UNTRANSLATED RNA; PVT1 LONG-NON-CODING RNA, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

AHI1 GENE; ARTICLE; ATG13 AMBRA1 GENE; CASE CONTROL STUDY; CLEC16A GENE; CONTROLLED STUDY; GENE; GENE LOCUS; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOME-WIDE ASSOCIATION STUDY; GENOTYPING TECHNIQUE; HERITABILITY; HUMAN; IMMUNOGLOBULIN A DEFICIENCY; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PVT1 GENE; QUANTITATIVE TRAIT LOCUS; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM; COHORT ANALYSIS; GENE REGULATORY NETWORK; GENETIC VARIATION; GENETICS; META ANALYSIS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AUTOPHAGY-RELATED PROTEINS; COHORT STUDIES; GENE REGULATORY NETWORKS; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; IGA DEFICIENCY; LECTINS, C-TYPE; MONOSACCHARIDE TRANSPORT PROTEINS; RNA, LONG NONCODING;

EID: 84990987996     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.3675     Document Type: Article

References (58)

1. Pan-Hammarström, Q. & Hammarström, L. Antibody defciency diseases. Eur. J. Immunol. 38, 327-333 (2008).
2. Suzuki, K. et al. Aberrant expansion of segmented flamentous bacteria in IgA-defcient gut. Proc. Natl. Acad. Sci. USA 101, 1981-1986 (2004).
3. Cong, Y., Feng, T., Fujihashi, K., Schoeb, T.R. & Elson, C.O. A dominant, coordinated T regulatory cell-IgA response to the intestinal microbiota. Proc. Natl. Acad. Sci. USA 106, 19256-19261 (2009).
4. Borte, S. et al. Interleukin-21 restores immunoglobulin production ex vivo in patients with common variable immunodefciency and selective IgA defciency. Blood 114, 4089-4098 (2009).
5. Cao, A.T. et al. Interleukin (IL)-21 promotes intestinal IgA response to microbiota. Mucosal Immunol. 8, 1072-1082 (2015).
6. Ferreira, R.C. et al. High-density SNP mapping of the HLA region identifes multiple independent susceptibility loci associated with selective IgA defciency. PLoS Genet. 8, e1002476 (2012).
7. Oen, K., Petty, R.E. & Schroeder, M.L. Immunoglobulin A defciency: genetic studies. Tissue Antigens 19, 174-182 (1982).
8. Ludvigsson, J.F., Neovius, M. & Hammarström, L. Association between IgA defciency & other autoimmune conditions: a population-based matched cohort study. J. Clin. Immunol. 34, 444-451 (2014).
9. Ferreira, R.C. et al. Association of IFIH1 and other autoimmunity risk alleles with selective IgA defciency. Nat. Genet. 42, 777-780 (2010).
10. Kiryluk, K. et al. Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens. Nat. Genet. 46, 1187-1196 (2014).
11. Nejentsev, S., Walker, N., Riches, D., Egholm, M. & Todd, J.A. Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science 324, 387-389 (2009).
12. Cunninghame Graham, D.S. et al. Association of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with systemic lupus erythematosus. PLoS Genet. 7, e1002341 (2011).
13. Li, Y. et al. Carriers of rare missense variants in IFIH1 are protected from psoriasis. J. Invest. Dermatol. 130, 2768-2772 (2010).
14. Gregersen, P.K. et al. Risk for myasthenia gravis maps to a (151) Pro→Ala change in TNIP1 and to human leukocyte antigen-B∗08. Ann. Neurol. 72, 927-935 (2012).
15. Shigemoto, T. et al. Identifcation of loss of function mutations in human genes encoding RIG-I and MDA5: implications for resistance to type I diabetes. J. Biol. Chem. 284, 13348-13354 (2009).
16. Van Eyck, L. et al. Brief report: IFIH1 mutation causes systemic lupus erythematosus with selective IgA defciency. Arthritis Rheumatol. 67, 1592-1597 (2015).
17. Okada, Y. et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 506, 376-381 (2014).
18. Boyle, A.P. et al. Annotation of functional variation in personal genomes using RegulomeDB. Genome Res. 22, 1790-1797 (2012).
19. ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57-74 (2012).
20. Tseng, Y.Y. et al. PVT1 dependence in cancer with MYC copy-number increase. Nature 512, 82-86 (2014).
21. Ringrose, A. et al. Evidence for an oncogenic role of AHI-1 in Sezary syndrome, a leukemic variant of human cutaneous T-cell lymphomas. Leukemia 20, 1593-1601 (2006).
22. Zhou, L.L. et al. AHI-1 interacts with BCR-ABL and modulates BCR-ABL transforming activity and imatinib response of CML stem/progenitor cells. J. Exp. Med. 205, 2657-2671 (2008).
23. Nazio, F. et al. mTOR inhibits autophagy by controlling ULK1 ubiquitylation, self-association and function through AMBRA1 and TRAF6. Nat. Cell Biol. 15, 406-416 (2013).
24. Pierdominici, M. et al. Role of autophagy in immunity and autoimmunity, with a special focus on systemic lupus erythematosus. FASEB J. 26, 1400-1412 (2012).
25. Clarke, A.J. et al. Autophagy is activated in systemic lupus erythematosus and required for plasmablast development. Ann. Rheum. Dis. 74, 912-920 (2015).
26. Pengo, N. et al. Plasma cells require autophagy for sustainable immunoglobulin production. Nat. Immunol. 14, 298-305 (2013).
27. Davison, L.J. et al. Long-range DNA looping and gene expression analyses identify DEXI as an autoimmune disease candidate gene. Hum. Mol. Genet. 21, 322-333 (2012).
28. Todd, J.A. et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat. Genet. 39, 857-864 (2007).
29. + T cells regulate immunoglobulin a selection and facilitate diversifcation of bacterial species responsible for immune homeostasis. Immunity 41, 152-165 (2014).
30. Chung, D., Yang, C., Li, C., Gelernter, J. & Zhao, H. GPA: a statistical approach to prioritizing GWAS results by integrating pleiotropy and annotation. PLoS Genet. 10, e1004787 (2014).
31. Li, J. et al. Association of CLEC16A with human common variable immunodefciency disorder and role in murine B cells. Nat. Commun. 6, 6804 (2015).
32. Schuster, C. et al. The autoimmunity-associated gene CLEC16A modulates thymic epithelial cell autophagy and alters T cell selection. Immunity 42, 942-952 (2015).
33. Yaspan, B.L. et al. Genetic analysis of biological pathway data through genomic randomization. Hum. Genet. 129, 563-571 (2011).
34. Lee, P.H., O'Dushlaine, C., Thomas, B. & Purcell, S.M. INRICH: interval-based enrichment analysis for genome-wide association studies. Bioinformatics 28, 1797-1799 (2012).
35. Onengut-Gumuscu, S. et al. Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers. Nat. Genet. 47, 381-386 (2015).
36. Schmidl, C. et al. The enhancer and promoter landscape of human regulatory and conventional T-cell subpopulations. Blood 123, e68-e78 (2014).
37. Fontenot, J.D. et al. Regulatory T cell lineage specifcation by the forkhead transcription factor Foxp3. Immunity 22, 329-341 (2005).
38. Bennett, C.L. et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27, 20-21 (2001).
39. Notarangelo, L.D. et al. Primary immunodefciencies: 2009 update. J. Allergy Clin. Immunol. 124, 1161-1178 (2009).
40. Magnusson, P.K. et al. The Swedish Twin Registry: establishment of a biobank and other recent developments. Twin Res. Hum. Genet. 16, 317-329 (2013).
41. Salvi, E. et al. Genomewide association study using a high-density single nucleotide polymorphism array and case-control design identifes a novel essential hypertension susceptibility locus in the promoter region of endothelial NO synthase. Hypertension 59, 248-255 (2012).
42. Mitchell, M.K., Gregersen, P.K., Johnson, S., Parsons, R. & Vlahov, D. The New York Cancer Project: rationale, organization, design, and baseline characteristics. J. Urban Health 81, 301-310 (2004).
43. Price, A.L. et al. Principal components analysis corrects for stratifcation in genome-wide association studies. Nat. Genet. 38, 904-909 (2006).
44. Price, A.L. et al. Long-range LD can confound genome scans in admixed populations. Am. J. Hum. Genet. 83, 132-135, author reply 135-139 (2008).
45. Kosoy, R. et al. Ancestry informative marker sets for determining continental origin and admixture proportions in common populations in America. Hum. Mutat. 30, 69-78 (2009).
46. Tian, C. et al. Analysis and application of European genetic substructure using 300 K SNP information. PLoS Genet. 4, e4 (2008).
47. Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559-575 (2007).
48. Delaneau, O., Zagury, J.F. & Marchini, J. Improved whole-chromosome phasing for disease and population genetic studies. Nat. Methods 10, 5-6 (2013).
49. Howie, B., Fuchsberger, C., Stephens, M., Marchini, J. & Abecasis, G.R. Fast and accurate genotype imputation in genome-wide association studies through pre-phasing. Nat. Genet. 44, 955-959 (2012).
50. Marchini, J. & Howie, B. Genotype imputation for genome-wide association studies. Nat. Rev. Genet. 11, 499-511 (2010).
51. Pruim, R.J. et al. LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics 26, 2336-2337 (2010).
52. Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B 57, 289-300 (1995).
53. Ogata, H. et al. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 27, 29-34 (1999).
54. Dixon, A.L. et al. A genome-wide association study of global gene expression. Nat. Genet. 39, 1202-1207 (2007).
55. Duan, S. et al. Genetic architecture of transcript-level variation in humans. Am. J. Hum. Genet. 82, 1101-1113 (2008).
56. He, X. et al. Sherlock: detecting gene-disease associations by matching patterns of expression QTL and GWAS. Am. J. Hum. Genet. 92, 667-680 (2013).
57. Yang, J., Lee, S.H., Goddard, M.E. & Visscher, P.M. GCTA: a tool for genome-wide complex trait analysis. Am. J. Hum. Genet. 88, 76-82 (2011).
58. Barrett, J.C. et al. Genome-wide association study and meta-analysis fnd that over 40 loci affect risk of type 1 diabetes. Nat. Genet. 41, 703-707 (2009).